Literature DB >> 7865847

Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells.

S A Fuqua1, M G Benedix, S Krieg, C N Weng, G C Chamness, S Oesterreich.   

Abstract

We present evidence that the mechanisms controlling induction of heat shock transcription factors (HSFs) and mRNA expression of the 27,000 molecular weight heat shock protein, hsp27, are diverse in human breast cancer cells. Heat shock accumulation of hsp27 RNA is associated with the activation of HSF in MDA-MB-231 cells. We have later passage MCF-7 breast cancer cell lines with elevated, constitutive expression of hsp27 mRNA, perhaps due to hsp27 gene amplification. Estradiol and heat shock treatment no longer affect the level of hsp27 mRNA in these cells. Heat induction of HSF is inhibited in cells overexpressing hsp27, although metal ions and amino acid analogs are still capable of activating HSF. These cells will provide a useful system for characterizing alternative pathways in HSF inhibition and activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865847     DOI: 10.1007/bf00665768

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  32 in total

1.  Identification of ecdysone response elements by analysis of the Drosophila Eip28/29 gene.

Authors:  L Cherbas; K Lee; P Cherbas
Journal:  Genes Dev       Date:  1991-01       Impact factor: 11.361

2.  Heat-inducible human factor that binds to a human hsp70 promoter.

Authors:  R E Kingston; T J Schuetz; Z Larin
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

3.  Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells.

Authors:  D D Mosser; N G Theodorakis; R I Morimoto
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

4.  The heat shock response is self-regulated at both the transcriptional and posttranscriptional levels.

Authors:  B J DiDomenico; G E Bugaisky; S Lindquist
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.

Authors:  S Oesterreich; C N Weng; M Qiu; S G Hilsenbeck; C K Osborne; S A Fuqua
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

6.  Transcription of the human hsp70 gene is induced by serum stimulation.

Authors:  B J Wu; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

7.  Molecular cloning and expression of a human heat shock factor, HSF1.

Authors:  S K Rabindran; G Giorgi; J Clos; C Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Posttranscriptional regulation of hsp70 expression in human cells: effects of heat shock, inhibition of protein synthesis, and adenovirus infection on translation and mRNA stability.

Authors:  N G Theodorakis; R I Morimoto
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

9.  Heat shock but not other stress inducers leads to the disruption of a sub-set of snRNPs and inhibition of in vitro splicing in HeLa cells.

Authors:  U Bond
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

Review 10.  Heat shock proteins: the search for functions.

Authors:  M J Schlesinger
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

View more
  2 in total

1.  Induction of Hsp22 (HspB8) by estrogen and the metalloestrogen cadmium in estrogen receptor-positive breast cancer cells.

Authors:  Xiankui Sun; Jean-Marc Fontaine; Ingrid Bartl; Babak Behnam; Michael J Welsh; Rainer Benndorf
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

2.  Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy.

Authors:  G Sliutz; J Karlseder; C Tempfer; L Orel; G Holzer; M M Simon
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.